EBM Eastwood Bio-Medical Canada Inc.

TSXV · CA · Healthcare · Biotechnology · eleotin.ca
1.139USD1.630 CAD · TSXV-0.61%Mkt Cap: 78.49M USDP/E: —

Eastwood Bio-Medical Canada Inc. markets, develops research, and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. The company distributes Eleotin, which provides natural…

Key Statistics

Company
Market Cap78.49M USD
Enterprise Value78.53M USD
Revenue (TTM)567.70K USD
Gross Profit385.17K USD
Net Income (TTM)-232.62K USD
Revenue/Share0.0084 USD
Last Price1.139 USD
Fiscal Year EndOct 2025
MR QuarterJul 2026
Employees—
CountryCA
SectorHealthcare
IndustryBiotechnology
ISINCA27783W1059
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-761.51
EV/Revenue138.34
P/S138.26
P/B-62.69
EPS (TTM)-0.0070 USD
EPS (Forward)—
52W Range
0.342573% of range1.440
52W High1.440 USD
52W Low0.3425 USD
Profitability
Gross Margin70.45%
Oper. Margin-22.03%
EBITDA Margin-18.17%
Profit Margin-42.55%
ROE20.42%
ROA-152.11%
ROIC—
ROCE—
Growth
Revenue Growth19.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF13.49K USD
CapEx (TTM)—
FCF Margin12.72%
FCF Yield0.09%
Net Debt42.03K USD
Net Debt/EBITDA-0.41
Net Debt/FCF0.58
Balance Sheet
Debt/Equity-0.05
Current Ratio0.05
Quick Ratio0.05
Book Value/Sh-0.02 USD
Cash/Share0.00 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.68.89M
Float21.17M
Insiders69.30%
Institutions0.00%
Short Interest
Short Ratio2.0d
Short % Out.0.01%
Shares Short4.69K
Short (prev mo.)1.01K
Technical
SMA 501.286 (-11.4%)
SMA 2000.8210 (+38.8%)
Beta0.32
S&P 52W Chg12.00%
Avg Vol (30d)2.84K
Avg Vol (10d)2.40K
Technical Indicators
RSI (14)39.9
MACD-0.0499
MACD Signal-0.0252
MACD Hist.-0.0247
BB Upper1.440 USD
BB Middle1.261 USD
BB Lower1.083 USD
BB Width28.28%
ATR (14)0.0866 USD
Vol Ratio (20d)2.67x

About Eastwood Bio-Medical Canada (CVE: EBM)

›

Eastwood Bio-Medical Canada (CVE: EBM) is listed on the TSX Venture Exchange, where its shares trade in CAD. It belongs to the Biotechnology industry, part of the Healthcare sector.

The shares were at 1.630 CAD on 19 November 2026, up 171.7% over 52 weeks. Its 52-week range is 0.4900 CAD to 2.060 CAD: the price is 20.9% below the high and 232.7% above the low.

Its market capitalisation is 112.28M CAD.

Eastwood Bio-Medical Canada reports return on equity of 20.4%, an operating margin of -22.0% and revenue up 19.4% year over year.

Its debt exceeds its cash by 60.12K CAD. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. The next earnings report is expected on 1 March 2027.